Invokamet 50 mg (Canagliflozin TABLET) 50 MG

Invokamet 50 mg tablets combine canagliflozin and metformin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Strength

50 MG

Pack Size

Manufacturer / TM Owner

JANSSEN INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Invokamet 50 mg tablets are used to manage type 2 diabetes in adults. This medication helps control blood sugar levels, often as part of a comprehensive diabetes management strategy. It is typically prescribed for individuals who require dual therapy with canagliflozin and metformin. What is Invokamet used for? It is primarily used to improve glycemic control in type 2 diabetes.

Side Effects

Common effects of Invokamet 50 mg tablets may include urinary tract infections, genital fungal infections, and gastrointestinal discomfort. Some users may experience increased urination or mild hypoglycemia. These effects vary among individuals and are not exhaustive.

Precautions & Warnings

Handle Invokamet 50 mg tablets with care, especially if you have kidney issues, liver problems, or a history of pancreatitis. Always follow your healthcare provider's guidance regarding usage and monitoring. Store at room temperature, away from moisture and heat.

Avoid Interactions

Invokamet 50 mg tablets may interact with certain medications, including diuretics, insulin, and other diabetes drugs. Alcohol consumption should be limited, as it can affect blood sugar levels. Inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Invokamet 50 mg tablets are used to manage type 2 diabetes by helping to control blood sugar levels.

Invokamet 50 mg tablets are taken orally, typically with meals, as directed by your healthcare provider.

Common side effects may include urinary tract infections, genital fungal infections, and gastrointestinal discomfort.

It is advisable to limit alcohol consumption while taking Invokamet, as it can affect blood sugar levels.

Individuals with severe kidney or liver problems, or a history of pancreatitis, should consult their healthcare provider before taking Invokamet.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.